PIVAC 2018 was held in Oslo, co-organized by the department of Cell Therpay. The conference permitted to share new advance in the field of vaccination and future prospects for immunotherapy.
Casey NP, Kleinmanns K, Forcados C, Gelebart PF, Joaquina S, Lode M, Benard E, Kaveh F, Caulier B, Helgestad Gjerde C, García de Jalón E, Warren DJ, Lindemann K, Rokkones E, Davidson B, Myhre MR, Kvalheim G, Bjørge L, McCormack E, Inderberg EM, Wälchli S(2024) Efficient CAR T cell targeting of the CA125 extracellular repeat domain of MUC16 J Immunother Cancer, 12(4) DOI 10.1136/jitc-2023-008179, PubMed 38604812
Maggadottir SM, Dueland S, Mensali N, Hamre H, Andresen PA, Myhre MR, Juul HV, Bigalke I, Lundby M, Hønnåshagen TK, Sæbøe-Larssen S, Josefsen D, Hagtvedt T, Wälchli S, Kvalheim G, Inderberg EM(2024) Transient TCR-based T cell therapy in a patient with advanced treatment-resistant MSI-high colorectal cancer Mol Ther(in press) DOI 10.1016/j.ymthe.2024.04.009, PubMed 38582964
Klee CH, Villatoro A, Casey NP, Inderberg EM, Wälchli S(2023) In vitro re-challenge of CAR T cells Methods Cell Biol, 183, 335-353 DOI 10.1016/bs.mcb.2023.06.003, PubMed 38548418
